Business Wire

Revvity Unveils a New Era of Automated Tuberculosis Testing

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today announced the launch of the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test. The Auto-Pure 2400 platform ...
Medscape

Contribution of Interferon Gamma Release Assays Testing to the Diagnosis of Latent Tuberculosis Infection in HIV-infected Patients

Background: Diagnosis and treatment of latent tuberculosis infection (LTBI) is the most effective strategy to control tuberculosis (TB) among patients with HIV infection. The tuberculin skin test (TST ...
Nasdaq

Revvity Gets FDA Approval For Automated Latent Tuberculosis Test

(RTTNews) - Revvity, Inc. (RVTY), Wednesday said that the U.S. Food and Drug Administration (FDA) has approved the Auto-Pure 2400 liquid handling platform with the T-SPOT. tuberculosis (TB) test. "The ...
CNN

Oxford Immunotec announces successful re-registration of the T-SPOT®.TB test in China

OXFORD, United Kingdom and MARLBOROUGH, Mass., April 21, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company, today announced that it has ...
EurekAlert!

New skin test improves tuberculosis diagnosis in children and adolescents

Tuberculosis (TB) remains a leading cause of illness and death among children worldwide, with nearly 1.3 million cases estimated in 2023 and more than half going undiagnosed. Current diagnostic tools, ...
NPR

Long a dream, it's now real: a fast and accurate TB test that doesn't need phlegm

That has been the question for nearly 150 years, when Dr. Robert Koch first identified the rod-shaped bacterium that causes tuberculosis. This serious respiratory illness is currently the world's ...